Qnostics
  • About
  • Products
    • Product Summary
    • Molecular Controls
    • QCMD Past Panels
    • Custom and Service Provision
  • News & Views
  • Contact

Category: Respiratory

Posted on 15th April 2020

SARS-CoV-2 whole pathogen molecular controls

SARS-CoV-2 – whole pathogen molecular controls are now available in Qnostics. Samples are representative of clinical human specimens and are traceable to an internal reference preparation in line with the requirements of ISO 17511:2003. The Panels are suitable for use with the majority of commercial and in-house molecular methods. For information, enquiries and technical bulletins,…

Posted on 11th May 2017

Investigation into the application of Droplet Digital PCR to cross-validate and standardise four human Adenovirus types in the absence of higher order standards

Posted on 1st May 2017

Standardisation of four types of human Adenovirus in the absence of a higher order standard

Posted on 12th August 2014

Launch of RSV and RV Molecular Controls

Qnostics Launches RSV and RV Molecular ‘Q’ Controls  Glasgow, United Kingdom, 12th August 2014 – Qnostics Ltd. today announced the addition of another 2 target members to its own brand products. The Qnostics ‘Q’ Control range now includes Respiratory Syncytial virus (RSV) and Rhinovirus (RV), which brings the number of targets in this range to…

Posted on 3rd July 2014

Launch of CE Marked CMV Molecular Controls

Glasgow, United Kingdom, 3rd July, 2014 – Qnostics Ltd. announced today that it has received CE Marked status for its new CMV molecular controls. These products are a welcome addition to the existing range of respiratory and transplant molecular controls. “The launch of the CMV CE Marked molecular controls is a major achievement for Qnostics.…

Posted on 7th January 2014

Launch of new Transplant & Respiratory Molecular Controls

Glasgow, United Kingdom, 7th January, 2014 – Qnostics Ltd. serving molecular laboratories, today announced it has launched several new molecular controls for use within the testing procedures for a variety of respiratory and transplant assays. “The launch of our new molecular controls allows the company to further strengthen its Transplant range of molecular controls as…

Categories

  • Dried Blood Spot
  • Evaluation Panels
  • Global Events
  • Molecular Controls
  • Products
  • Respiratory
  • Studies
  • Technology
  • Transplant
  • Uncategorised

Archives

  • May 2020
  • April 2020
  • October 2019
  • November 2017
  • October 2017
  • September 2017
  • May 2017
  • October 2016
  • February 2016
  • August 2014
  • July 2014
  • March 2014
  • January 2014

Tags

adenovirus ADV BKV CE CMV Conferences digitalPCR EBV EMMD encephalitis HHV6 HIV HSV influenza JCV meningitis molecular-controls molecular-diagnostics molecular-medicine molecular-Q-controls multipathogens parainfluenza positivecontrols product-launch Q-controls quality RNA RSV RV viral VZV

© 2021 Qnostics

Connect With Us

Back to top